Knowledge Sourcing Intelligence (KSI)
Home/Healthcare/Biotechnology/Global Human Microbiome Market

Global Human Microbiome Market - Strategic Insights and Forecasts (2025-2030)

Industry research exploring microbial ecosystem studies and their impact on next-generation medical therapies.

Market Size in 2025
USD 0.94 billion
Market Size in 2030
USD 2.38 billion
CAGR 2025-2030
20.42%
Study Period
2020-2030
Single User License
$3,950
Formats
PDF, Excel, PPT, Dashboard
Pages
148
Data update
2026 refresh included
Report OverviewSegmentationTable of ContentsCustomize Report

The human microbiome market will grow at a CAGR of 20.42% to reach US$2.38 billion in 2030 from US$0.94 billion in 2025.

Global Human Microbiome Market - Strategic Insights and Forecasts (2025-2030) market growth projection from $0.94B in 2025 to $2.38B by 2030 at a CAGR of 20.42%.
Global Human Microbiome Market - Strategic Insights and Forecasts (2025-2030) market growth projection from $0.94B in 2025 to $2.38B by 2030 at a CAGR of 20.42%.

Major factors driving the global human microbiome market growth are increasing instances of lifestyle diseases, diarrheal infections, predominant changes in the lifestyle of the global population, and an increase in the aged population and its applications in healthcare. Moreover, technological enhancements in biomedical sciences and growing research investment in technology and product sectors is also positively impacting the market growth positively. However, lack of awareness about the use and advantages of prebiotics and probiotics and government restrictions on their usage are major challenges for the market players.

The global human microbiome market report provides a detailed analysis of the industry landscape, offering strategic and executive-level insights supported by data-driven forecasts and analysis. This regularly updated report equips decision-makers with actionable intelligence on current market trends, emerging opportunities, and competitive dynamics. It explores consumer demand across various regions and product types, such as therapeutics, diagnostics, and probiotics, while also examining purchasing behaviours and key customer segments. Additionally, the report delves into technological advancements, key government policies, regulation.

SEGMENT SHARE DISTRIBUTION (ILLUSTRATIVE)
Market Share Breakdown — By Product
Unlock Exact Segment Splits →
Probiotics
Prebiotics
Supplements
Others
Bar lengths are illustrative. The full report gives historical and forecast revenue for each segment.
HISTORICAL & FORECAST DATA TABLE (ILLUSTRATIVE)
By Product — Revenue by Year (2025–2030)
Segment202520262027202820292030CAGR (%)
Probiotics
Prebiotics
Supplements
Others
Total Market SizeUSD 0.94 billionUSD 2.38 billion20.42%
Unlock Full Historical & Forecast Excel Databook (2025–2030)
Download Sample Excel →

Human Microbiome Market Scope:

Report Metric Details
Total Market Size in 2025 USD 0.94 billion
Total Market Size in 2030 USD 2.38 billion
Forecast Unit Billion
Growth Rate 20.42%
Study Period 2020 to 2030
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2030
Segmentation Product, Disease, Application, Geography
Companies
  • Seres Therapeutics
  • Microbiome Therapeutics Innovation Group
  • Vedanta Biosciences Inc.
  • Metabiomics
  • Ferring Pharmaceuticals
Customization Scope 15% Free Customization included with purchase — Request Custom Breakdown →
Sample & Data Access PDF Sample, Excel Databook & Analyst Briefing — Download Free Sample →

Need country-level data or a custom regional split for your target market?Request Regional Data →

Market Segmentation

By Product

Probiotics
Prebiotics
Supplements
Others

By Disease

Diabetes
Autoimmune Disorder
Cancer
Obesity
Others

By Application

Diagnostics
Therapeutics

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Italy
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Thailand
Others

Table of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL HUMAN MICROBIOME MARKET BY PRODUCT

5.1. Introduction

5.2. Probiotics

5.3. Prebiotics

5.4. Supplements

5.5. Others

6. GLOBAL HUMAN MICROBIOME MARKET BY DISEASE

6.1. Introduction

6.2. Diabetes

6.3. Autoimmune Disorder

6.4. Cancer

6.5. Obesity

6.6. Others

7. GLOBAL HUMAN MICROBIOME MARKET BY APPLICATION

7.1. Introduction

7.2. Diagnostics

7.3. Therapeutics

8. GLOBAL HUMAN MICROBIOME MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Italy

8.4.6. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Thailand

8.6.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Seres Therapeutics

10.2. Microbiome Therapeutics Innovation Group

10.3. Vedanta Biosciences Inc.

10.4. Metabiomics

10.5. Ferring Pharmaceuticals

10.6. Finch Therapeutics

10.7. BiomeBank

10.8. Biohm Technologies

10.9. Resbiotic

10.10. Immuron Limited

10.11. Maat Pharma

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Navigate
Trusted by industry leaders
AmazonABBFujifilmHitachiMcKinseyAmazonABBFujifilmHitachiMcKinsey
Report IDKSI061610813
Last updated
Pages148

Frequently asked questions

What will be the human microbiome market size by 2030?

The human microbiome market is expected to reach a total market size of US$2.38 billion by 2030.

What is the size of the human microbiome market?

Human Microbiome Market is valued at US$0.94 billion in 2025.

What are the growth prospects for the human microbiome market?

The human microbiome market is expected to grow at a CAGR of 20.42% during the forecast period.

What factors are anticipated to drive the human microbiome market growth?

Key drivers include rising gut health awareness, microbiome-based therapies, personalized medicine, and increasing research investments.

Which region holds the largest share of the human microbiome market?

The North American region is anticipated to hold a significant share of the human microbiome market.

Cite this report

Knowledge Sourcing Intelligence. (Mar 2026). Global Human Microbiome Market - Strategic Insights and Forecasts (2025-2030). https://www.knowledge-sourcing.com/report/human-microbe-market

Get notified when this report is updated